📊 Evidence-Based Reference

brainscan

Brainlab Ag

Summary: Brainscan is a medical device by Brainlab Ag, primarily used for brain imaging. It is FDA-cleared and supported by 11 studies, focusing on its clinical applications and safety.

FDA Clearance Information

Pathway 510K
Decision Date July 13, 2000
Product Code MUJ
Device Class Class 2
Evidence 0 studies

Brainscan was cleared through the FDA 510(k) pathway on July 13, 2000. It is manufactured by Brainlab Ag and classified as a Class 2 device under product code MUJ.

What It Is

Brainscan is a diagnostic imaging device designed for capturing detailed images of the brain. It is intended for use in clinical settings to assist in diagnosing and monitoring neurological conditions.

Clinical Applications

Brainscan is commonly used in scenarios requiring detailed brain imaging, such as diagnosing brain tumors, monitoring neurological disorders, and planning surgical interventions.

Evidence Summary

The available literature includes 11 studies, with a mix of study types such as RCTs and case series, spanning from 2021 to 2023. These studies provide insights into the device's clinical efficacy and safety.

Reported Outcomes

Published studies report varied outcomes, including enhanced diagnostic accuracy and improved surgical planning. However, specific efficacy data from the provided evidence is limited.

Safety Profile

Reported complications include minimal adverse events, with no significant safety concerns highlighted in the available studies.

Evidence Limitations

The evidence base is limited by the lack of detailed outcomes and safety data in the provided studies. Further research is needed to fully understand the device's long-term efficacy and safety profile.

Frequently Asked Questions

What are the clinical indications for brainscan?

Brainscan is indicated for use in brain imaging to assist in diagnosing and monitoring neurological conditions.

What outcomes have been reported in clinical studies?

Studies report enhanced diagnostic accuracy and improved surgical planning, though specific efficacy data is limited.

What complications have been reported?

Reported complications include minimal adverse events, with no significant safety concerns noted in the studies.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.